Bausch Health
BHC
#4163
Rank
NZ$3.38 B
Marketcap
$9.15
Share price
6.00%
Change (1 day)
-36.52%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2023 (TTM): -$4.29

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is -$4.44. In 2022 the company made an earnings per share (EPS) of -$1.04 an increase over its 2021 EPS that were of -$4.44.

EPS history for Bausch Health from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.29313.36%
2022-$1.04-76.64%
2021-$4.4468.45%
2020-$2.64-68.91%
2019-$8.48-57.11%
2018-$19.77-272.22%
2017$11.48-199.29%
2016-$11.56798.7%
2015-$1.29-128.31%
2014$4.54-204.62%
2013-$4.34602.7%
2012-$0.62-171.15%
2011$0.87-143.96%
2010-$1.98-206.57%
2009$1.85-11.2%
2008$2.092.46%
2007$2.04-7.58%
2006$2.21-14.29%
2005$2.5754%
2004$1.67-500%
2003-$0.42-141.67%
2002$1.00-4.76%
2001$1.05-175%
2000-$1.40-268%
1999$0.8414.94%
1998$0.7320.83%
1997$0.6053.83%
1996$0.39

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.67-62.37%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.45-89.84%๐Ÿ‡บ๐Ÿ‡ธ USA